| PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects |
22 |
| Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST |
21 |
| Performance evaluation of the next generation solid-state digital photon counting PET/CT system |
16 |
| Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-18-FDG PET/CT analysis |
12 |
| Synthesis and preclinical evaluation of novel F-18-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with F-18-DCFPyl and F-18-PSMA1007 |
11 |
| Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer |
10 |
| Biokinetic and dosimetric aspects of (CuCl2)-Cu-64 in human prostate cancer: possible theranostic implications |
10 |
| [F-18]Fluciclovine PET discrimination between high- and low-grade gliomas |
10 |
| Dopamine transporter imaging with [F-18]FE-PE2I PET and [I-123]FP-CIT SPECTa clinical comparison |
10 |
| Analysis of differences between Tc-99m-MAA SPECT- and Y-90-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy |
10 |
| Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity |
9 |
| Y-90-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer |
8 |
| Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe |
8 |
| The value of Tc-99m-MAA SPECT/CT for lung shunt estimation in Y-90 radioembolization: a phantom and patient study |
8 |
| Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical Ga-68-PSMA PET/MR |
8 |
| Voxel-based identification of local recurrence sub-regions from pre-treatment PET/CT for locally advanced head and neck cancers |
8 |
| Evaluation of data-driven respiratory gating waveforms for clinical PET imaging |
7 |
| Statistical evaluation of test-retest studies in PET brain imaging |
7 |
| Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using Ga-68-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques |
7 |
| Prognostic value of simultaneous F-18-FDG PET/MRI using a combination of metabolo-volumetric parameters and apparent diffusion coefficient in treated head and neck cancer |
7 |
| F-18-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition |
7 |
| Concomitant Lu-177-DOTATATE and capecitabine therapy in malignant paragangliomas |
7 |
| Radiomics of the primary tumour as a tool to improve F-18-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer |
7 |
| Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review |
7 |
| Head-to-head comparison of image quality between brain F-18-FDG images recorded with a fully digital versus a last-generation analog PET camera |
7 |
| Preclinical investigations and first-in-human application of Tb-152-PSMA-617 for PET/CT imaging of prostate cancer |
7 |
| Impact of external cooling with icepacks on Ga-68-PSMA uptake in salivary glands |
7 |
| Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [Lu-177-[DOTA Tyr3]-octreotate |
7 |
| Bone marrow cell homing to sites of acute tibial fracture: Zr-89-oxine cell labeling with positron emission tomographic imaging in a mouse model |
7 |
| PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma |
6 |
| Accuracy of tumor segmentation from multi-parametric prostate MRI and F-18-choline PET/CT for focal prostate cancer therapy applications |
6 |
| The use of a proposed updated EARL harmonization of F-18-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations |
6 |
| In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET |
6 |
| No significant difference found in PET/MRI CBF values reconstructed with CT-atlas-based and ZTE MR attenuation correction |
6 |
| Comparison of the radiolabeled PSMA-inhibitor In-111-PSMA-617 and the radiolabeled GRP-R antagonist In-111-RM2 in primary prostate cancer samples |
6 |
| A semi-automatic technique to quantify complex tuberculous lung lesions on F-18-fluorodeoxyglucose positron emission tomography/computerised tomography images |
6 |
| Ra-223-dichloride therapy of bone metastasis: optimization of SPECT images for quantification |
6 |
| Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide Sc-47 |
5 |
| Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT |
5 |
| Biodistribution and post-therapy dosimetric analysis of [Lu-177]Lu-DOTA(ZOL) in patients with osteoblastic metastases: first results |
5 |
| Repeatability of [F-18]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients |
5 |
| Visualization of ischemic stroke-related changes on F-18-THK-5351 positron emission tomography |
5 |
| Evaluation of apoptosis imaging biomarkers in a genetic model of cell death |
5 |
| Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics |
5 |
| [C-11]SCH23390 binding to the D-1-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis |
5 |
| A novel partial volume correction method for accurate quantification of [F-18] flortaucipir in the hippocampus |
5 |
| First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist Ga-68-NODAGA-MJ9 |
5 |
| Parathyroid imaging with F-18-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study |
5 |
| Impact of acquisition time and penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm on a Si-photomultiplier-based PET-CT system for F-18-FDG |
5 |
| Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors |
5 |
